Form 4 for MLAB MESA LABORATORIES INC /CO/
Accepted 2022-03-25 00:00:00 ET · period of report 2022-03-23 · accession 0001228924-22-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2022-03-25 | 2022-03-23+ | MLAB | Sakys John | CFO | S - Sale+OE | $251.23 | -1,600 | 8,184 | -16% | -$402.0K |
| D | 2022-03-25 | 2022-03-23 | MLAB | Sakys John | CFO | M - OptEx | $51.85 | +1,600 | 9,114 | +21% | +$83.0K |
| D | 2022-03-25 | 2022-03-23 | MLAB | Sakys John | CFO | X - OptEx | $0.00 | -1,600 | 26.7K | -6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-24 | S | D | 670 | $251.15 | 7,514 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on December 13, 2021 |
| 2 | Common | Common Stock | 2022-03-23 | S | D | 930 | $251.29 | 8,184 | D | — | — | (F2) Sale reported on this Form 4 was effected pursuant to a Rule 10B5-1 trading plan, adopted by the reporting person on December 13, 2021 |
| 3 | Common | Common Stock | 2022-03-23 | M | A | 1,600 | $51.85 | 9,114 | D | — | — | |
| 4 | Derivative | Non Qualified Stock Option | 2022-03-23 | X | D | 1,600 | $0.00 | 26,671 | D | $51.85 · 2014-04-01 to 2023-04-01 | 1,600 Common Stock | (F1) 1/4 exercisable on each anniversary date of the 04-01-2013 grant date |